Dr. Weiner is an Adjunct Professor at University of North Carolina and a Drug Development Consultant specializing in Model-Based Drug Development and PKPD training. He has specialties in PK/PD Modeling and Pharmacometrics.
Dr. Daniel Weiner was appointed on May, 2017 as a Board of Director.